ConductScience.org, home

Paper6237664

In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.

Uchida A and 4 others. Br J Cancer, 1984. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells. Papers, record 6237664. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6237664

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
PubMed
Journal
Br J Cancer
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.26
iCite
Revised in PubMed
2019-05-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uchida AA
2Yanagawa EE
3Kokoschka EME M
4Micksche MM
5Koren HSH S

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
Interferon Type IMajor topic
Killer Cells, NaturalMajor topic
T-Lymphocytes, RegulatoryMajor topic
Cells, Cultured
Humans
Melanoma

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1163658Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.Blood1975https://conductscience.org/library/papers/163658PubMed
2650156
Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
J Exp Med1978https://conductscience.org/library/papers/650156PubMed
3566386Enhanced NK cell activity in mice injected with interferon and interferon inducers.Nature1978https://conductscience.org/library/papers/566386PubMed
4503223Induction and kinetics of natural killer cells in humans following interferon therapy.Nature1979https://conductscience.org/library/papers/503223PubMed
5524066Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells.Scand J Immunol1979https://conductscience.org/library/papers/524066PubMed
66154092Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells.J Immunol1980https://conductscience.org/library/papers/6154092PubMed
76157064Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease.Lancet1980https://conductscience.org/library/papers/6157064PubMed
895205Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.Nature1979https://conductscience.org/library/papers/95205PubMed
96159812Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.Ann Intern Med1980https://conductscience.org/library/papers/6159812PubMed
106162198Effect of leucocyte interferon on natural killer cells in healthy volunteers.Scand J Immunol1980https://conductscience.org/library/papers/6162198PubMed
116166575Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon.Int J Cancer1980https://conductscience.org/library/papers/6166575PubMed
126166701Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.J Exp Med1981https://conductscience.org/library/papers/6166701PubMed
136174467In vitro augmentation of natural killing activity by OK-432.Int J Immunopharmacol1981https://conductscience.org/library/papers/6174467PubMed
146175787Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population.J Natl Cancer Inst1982https://conductscience.org/library/papers/6175787PubMed
156175788Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.J Natl Cancer Inst1982https://conductscience.org/library/papers/6175788PubMed
166461792Generation of suppressor cells for natural killer activity in cancer patients after surgery.J Natl Cancer Inst1982https://conductscience.org/library/papers/6461792PubMed
176176319Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.Cancer Res1982https://conductscience.org/library/papers/6176319PubMed
186176642Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity.J Immunol1982https://conductscience.org/library/papers/6176642PubMed
196177770Inhibition of natural killer activity by human bronchoalveolar macrophages.J Immunol1982https://conductscience.org/library/papers/6177770PubMed
206219961Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.Int J Cancer1983https://conductscience.org/library/papers/6219961PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn Papers
9384304Gamma interferon prevents diabetes in the BB rat.Clin Diagn Lab Immunol1997https://conductscience.org/library/papers/9384304

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6237664

GET https://conductscience.org/api/papers/v1/6237664/references?page=2